Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial access: a double-blind, randomized trial
Authors:
- K RuetzlerK Ruetzler
- B SimaBSB Sima
- L MayerLML Mayer
- A GolescuAGA Golescu
- D DunklerDDD Dunkler
- W JaegerW Jaeger
- M HoeferlMHM Hoeferl
- J YouJYJ You
- D.I. SesslerDSD.I. Sessler
- G GrubhoferGGG Grubhofer
- D HutschalaDHD Hutschala
- 1 November 2012
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 109 (5) , 790-796
Abstract
Arterial catheterization is painful and is associated with patient stress and anxiety. Analgesia is usually provided by subcutaneous injection of local anaesthetic. An alternative is topical anaesthesia, such as Rapydan which is a novel topical anaesthetic patch containing 70 mg each of lidocaine and tetracaine. We therefore tested the hypothesis that Rapydan patch analgesia is non-inferior to subcutaneous local anaesthetic. Ninety patients undergoing elective major cardiac surgery were included in this prospective, double-blind clinical trial. Patients were randomly assigned to receive either a lidocaine/tetracaine patch, followed by subcutaneous injection 0.5 ml of normal saline solution, or placebo patch with subsequent subcutaneous injection of 0.5 ml of lidocaine 1%. Pain during arterial catheterization using 100-mm-long visual analogue scale (VAS) was the primary outcome. Other outcomes were pain during anaesthetic/saline injection and plasma tetracaine concentrations. VAS pain scores during arterial puncture were comparable in both groups and Rapydan was non-inferior to subcutaneous lidocaine. Pain scores at the time of subcutaneous injection were significantly lower (better) in patients assigned to the lidocaine/tetracaine patch than to lidocaine (P=0.001). Plasma tetracaine concentrations never exceeded the detection limit of 25 ng ml(-1) at any time in any patient. Both the lidocaine/tetracaine patch and subcutaneous injection of lidocaine provided comparable pain control during arterial catheter insertion. Subcutaneous lidocaine caused discomfort during injection, whereas the lidocaine/tetracaine patch required placement 20 min before the procedure. Given adequate time, the patch provided better overall analgesia by obviating the need for subcutaneous infiltration.Keywords
This publication has 22 references indexed in Scilit:
- Patient safety during anaesthesia: incorporation of the WHO safe surgery guidelines into clinical practiceCurrent Opinion in Anaesthesiology, 2010
- The effect of a new topical local anaesthetic delivery system on forearm skin blood flow reactivity*Anaesthesia, 2009
- The Analgesic Properties of Scalp Infiltrations with Ropivacaine After Intracranial Tumoral ResectionAnesthesia & Analgesia, 2009
- Is the Allen test reliable enough?European Journal of Cardio-Thoracic Surgery, 2007
- Use of the Synera™ Patch for Local Anesthesia Before Vascular Access Procedures: A Randomized, Double-Blind, Placebo-Controlled StudyPain Medicine, 2007
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain, 2005
- Skin Capillary Appearance and Skin Microvascular Perfusion Due to Topical Application of Analgesia CreamMicrovascular Research, 2000
- Effects on Skin Blood Flow by Provocation during Local AnalgesiaMicrovascular Research, 2000
- Increasing the reliability and validity of pain intensity measurement in chronic pain patientsPain, 1993
- Rheumatoid arthritis: determination of pain characteristics and comparison of RAI and VAS in its measurementPain, 1990